Chumakov M P, Boĭko V M, Malyshkina L P, Mel'nikova S K, Rodin V I
Vopr Virusol. 1987 Mar-Apr;32(2):175-83.
During the autumn-winter epidemic of influenza-like diseases in December, 1983--first quarter, 1984, in Moscow commissioned coded observations on the effectiveness of prophylactic vaccination against influenza of 3-7-year-old children with a preparation "Grippovak SE-AZh" were carried out in day-care centers. In the previous large-scale trials, 1981-1984, the "Grippovak" had been evaluated positively as a completely harmless, serologically and immunologically active preparation reducing 3-3.5-fold the number of laboratory-verified cases of viral type A and B influenza in the vaccinees. In 1986, however, the "Journal of Microbiology, Epidemiology, Immunology" (JMEI, 2: 49-54) published a paper whose authors, on behalf of the Commission which had checked the preparation in the day-care centers (Z.A. Bashliaeva, A.A. Sumarokov, et al.), came to a conclusion that "Grippovak" was ineffective in children. Other members of the above Commission disagreeing with this conclusion made a repeat analysis of the decoded materials of the observations in the day-care centers using computer methods and demonstrated that because of significant prevalence of non-influenza ARD cases and recurrent (up to 44%) ARD cases in children in the 4 months of observation, it was impossible to judge the effectiveness of the vaccine by comparison of the total incidence of influenza and ARD from the clinical data alone in the vaccinees and controls.(ABSTRACT TRUNCATED AT 250 WORDS)
1983年12月至1984年第一季度,莫斯科出现秋冬流感样疾病疫情期间,在日托中心对3至7岁儿童使用“Grippovak SE-AZh”制剂进行流感预防性疫苗接种效果的编码观察。在1981 - 1984年之前的大规模试验中,“Grippovak”被积极评价为一种完全无害、具有血清学和免疫学活性的制剂,可使疫苗接种者中经实验室验证的甲型和乙型流感病例数减少3至3.5倍。然而,1986年《微生物学、流行病学、免疫学杂志》(JMEI,2:49 - 54)发表了一篇论文,其作者代表在日托中心检查该制剂的委员会(Z.A. 巴什利亚耶娃、A.A. 苏马罗科夫等人)得出结论,认为“Grippovak”对儿童无效。上述委员会的其他成员不同意这一结论,他们使用计算机方法对在日托中心观察的解码材料进行了重新分析,并表明由于在4个月的观察期内儿童中非流感急性呼吸道疾病病例和复发性(高达44%)急性呼吸道疾病病例的显著流行,仅通过临床数据比较疫苗接种者和对照组中流感和急性呼吸道疾病的总发病率,无法判断疫苗的有效性。(摘要截取自250词)